Verapamil Hydrochloride

ANDA 70577, held by Hospira. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 70577 (Verapamil Hydrochloride), held by Hospira, was first approved by FDA on Feb 2, 1987, with 8 approved supplements and 0 published complete response letters.

First approved: Feb 2, 1987
Supplements approved: 8
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 9 submissions below

Date	Submission	Status	Documents
Feb 2, 1987	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Verapamil Hydrochloride2.5MG/ML · injectable;injection	Verapamil Hydrochloride	Discontinued

All 9 submissions, including labeling and manufacturing supplements


Feb 14, 2001	Supplement 11Manufacturing	Approved	None posted
Mar 4, 1996	Supplement 9Labeling	Approved	None posted
Dec 22, 1995	Supplement 10Manufacturing	Approved	None posted
Apr 28, 1992	Supplement 3Manufacturing	Approved	None posted
Apr 28, 1992	Supplement 4Manufacturing	Approved	None posted
Mar 21, 1991	Supplement 7Labeling	Approved	None posted
Nov 1, 1990	Supplement 6Labeling	Approved	None posted
Mar 29, 1990	Supplement 5Labeling	Approved	None posted
Feb 2, 1987	Original application	Approved	None posted

Identifiers

Application: ANDA 70577
Drugs@FDA: Overview at FDA
Company: Hospira

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters